表紙
市場調查報告書

肺炎球菌疫苗的全球市場:產業分析,市場規模,佔有率,成長,趨勢,預測 2018年∼2026年

Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版商 Transparency Market Research 商品編碼 600060
出版日期 內容資訊 英文 285 Pages
商品交期: 最快1-2個工作天內
價格
肺炎球菌疫苗的全球市場:產業分析,市場規模,佔有率,成長,趨勢,預測 2018年∼2026年 Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日期: 2018年10月26日內容資訊: 英文 285 Pages
簡介

本報告提供全球肺炎球菌疫苗市場調查,市場概要,各產品類型、通路、部門、各國市場規模的變化與預測,市場成長要素及阻礙因素,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查範圍和市場區隔
  • 調查的重點

第2章 前提條件與調查方法

  • 前提條件與簡稱
  • 調查方法

第3章 摘要整理

  • 市場規模:各地區(成果值、預測值)
  • 市場概述

第4章 市場概要

  • 市場規模的預測(以金額為準)
  • 全球肺炎球菌疫苗市場預測
  • 已通過核准產品&開發中產品的概述

第5章 市場動態

  • 成長要素
    • 政府的全面疫苗接種計劃的計劃、實施
    • 公民營的肺炎球菌結合物疫苗的研究開發的投資擴大
  • 阻礙因素
    • 肺炎球菌疫苗的開發期間長與成本高
  • 市場機會
    • 血清型不同的多效價結合物疫苗的開發
  • 市場趨勢
    • 公民營合作關係

第6章 全球肺炎球菌疫苗市場分析:各產品類型

  • 簡介
  • 市場佔有率分析:各產品類型
  • 市場分析:各產品類型
    • Synflorix
    • Prevenar-13
    • PCV 13(開發平台)
    • V114(Merck)
    • PCV-20(Pfizer)
    • PCV-10(SII)
    • PPSV- 23

第7章 全球肺炎球菌疫苗市場分析:各銷售管道

  • 簡介
  • 市場佔有率分析:各銷售管道
  • 市場分析:各銷售管道
    • 批發業
    • 專門公司
    • 公共機關
    • 其他

第8章 全球肺炎球菌疫苗市場分析:各部門

  • 簡介
  • 市場佔有率分析:各部門
  • 市場分析:各部門
    • 公共
    • 民間

第9章 美國的肺炎球菌疫苗市場

  • 市場佔有率分析:各產品
  • 市場預測:各產品
    • Prevanar-13
    • V114
    • PCV-20
    • PCV-10(SII)
    • Pneumovax-23
  • 市場佔有率分析:各銷售管道
  • 市場預測:各銷售管道
    • 批發業
    • 專門公司
    • 公共機關
    • 其他
  • 市場佔有率分析:各部門
  • 市場預測:各部門
    • 民間
    • 公共

第10章 加拿大的肺炎球菌疫苗市場

第11章 德國的肺炎球菌疫苗市場

第12章 英國的肺炎球菌疫苗市場

第13章 法國的肺炎球菌疫苗市場

第14章 義大利的肺炎球菌疫苗市場

第15章 西班牙的肺炎球菌疫苗市場

第16章 比利時的肺炎球菌疫苗市場

第17章 印度的肺炎球菌疫苗市場

第18章 中國的肺炎球菌疫苗市場

第19章 日本的肺炎球菌疫苗市場

第20章 澳洲的肺炎球菌疫苗市場

第21章 紐西蘭的肺炎球菌疫苗市場

第22章 巴西的肺炎球菌疫苗市場

第23章 墨西哥的肺炎球菌疫苗市場

第24章 其他地區的肺炎球菌疫苗市場

第25章 競爭情形

  • 市場佔有率分析:各企業
  • 企業簡介
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • SK Chemicals
    • Serum Institute of India Pvt. Ltd.
    • GlaxoSmithKline plc
    • Sanofi
    • Walvax Biotechnology Co., Ltd.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Title:
Pneumococcal Vaccines Market (Product - Synflorix, Prevenar-13, PCV 13, V114, PCV-20, PCV-10, PPSV-23; Distribution Channel - Wholesalers (pharmacy channel), Specialized Companies, Public Authorities; Sector - Public, Private) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Pneumococcal Vaccines Market: Overview

This report analyzes the current and future scenario of the global pneumococcal vaccines market. Increase in patient population, growth of the pharmaceutical industry, rise in government investments for vaccination programs, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global pneumococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, distribution channel, sector, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pneumococcal vaccines market.

Global Pneumococcal Vaccines Market: Key Segments

Based on product type, the global pneumococcal vaccines market has been segmented into Synflorix, Prevenar-13, PCV 13 (pipeline), V114 (Merck), PCV-20 (Pfizer), PCV-10 (SII), and PPSV- 23. Each of these segments is categorized into pediatric and adults. In terms of distribution channel, the global market has been classified into wholesalers (pharmacy channel), specialized companies, public authorities, and others. Based on sector, the market has been bifurcated into private and public. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Pneumococcal Vaccines Market: Regional Outlook

In terms of region, the global pneumococcal vaccines market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Belgium, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World (Middle East and Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global pneumococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd.

The global pneumococcal vaccines market has been segmented as below:

Global Pneumococcal Vaccines Market, by Product Type

  • Synflorix
    • Pediatric
    • Adult
  • Prevenar-13
    • Pediatric
    • Adult
  • PCV 13 (pipeline)
    • Pediatric
    • Adult
  • V114 (Merck)
    • Pediatric
    • Adult
  • PCV-20 (Pfizer)
    • Pediatric
    • Adult
  • PCV-10 (SII)
    • Pediatric
    • Adult
  • PPSV- 23
    • Pediatric
    • Adult

Global Pneumococcal Vaccines Market, by Distribution Channel

  • Wholesalers (pharmacy channel)
  • Specialized Companies
  • Public Authorities
  • Others

Global Pneumococcal Vaccines Market, by Sector

  • Public
  • Private

Global Pneumococcal Vaccines Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Belgium
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of the World
    • Middle East
    • Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Pneumococcal Vaccines Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
  • 3.2. Global Pneumococcal Vaccines Market: Market Snapshot, 2016

4. Market Overview

  • 4.1. Overview
  • 4.2. Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast, 2016-2026
  • 4.3. Global Pneumococcal Vaccines Market Outlook
  • 4.4. Approved & Pipeline Products Snapshot

5. Market Dynamics

  • 5.1. Drivers
    • 5.1.1. Government participation in design & implementation of comprehensive vaccination programs
    • 5.1.2. Increase in investments by public & private players in R&D of conjugate pneumococcal vaccines
  • 5.2. Restraints
    • 5.2.1. Longer timeline and high cost associated with development of pneumococcal vaccines
  • 5.3. Opportunities
    • 5.3.1. Development of multivalent conjugated vaccines with different serotypes
  • 5.4. Trends
    • 5.4.1. Public-Private Partnerships

6. Global Pneumococcal Vaccines Market Analysis, by Product Type

  • 6.1. Introduction
  • 6.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 6.3. Pneumococcal Vaccines Market Analysis, by Product Type
    • 6.3.1. Synflorix
      • 6.3.1.1. Pediatric
      • 6.3.1.2. Adult
    • 6.3.2. Prevenar-13
      • 6.3.2.1. Pediatric
      • 6.3.2.2. Adult
    • 6.3.3. PCV 13 (pipeline)
      • 6.3.3.1. Pediatric
      • 6.3.3.2. Adult
    • 6.3.4. V114 (Merck)
      • 6.3.4.1. Pediatric
      • 6.3.4.2. Adult
    • 6.3.5. PCV-20 (Pfizer)
      • 6.3.5.1. Pediatric
      • 6.3.5.2. Adult
    • 6.3.6. PCV-10 (SII)
      • 6.3.6.1. Pediatric
      • 6.3.6.2. Adult
    • 6.3.7. PPSV- 23
      • 6.3.7.1. Pediatric
      • 6.3.7.2. Adult

7. Global Pneumococcal Vaccines Market Analysis, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 7.3. Pneumococcal Vaccines Market Analysis, by Distribution Channel
    • 7.3.1. Wholesalers
    • 7.3.2. Specialized Companies
    • 7.3.3. Public Authorities
    • 7.3.4. Others

8. Global Pneumococcal Vaccines Market Analysis, by Sector

  • 8.1. Introduction
  • 8.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 8.3. Pneumococcal Vaccines Market Analysis, by Sector
    • 8.3.1. Public
    • 8.3.2. Private

9. U.S. Pneumococcal Vaccines Market Analysis

  • 9.1. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 9.2. U.S. Pneumococcal Vaccines Market Forecast, by Product Type
    • 9.2.1. Prevanar-13
    • 9.2.2. V114
    • 9.2.3. PCV-20
    • 9.2.4. Pneumovax-23
  • 9.3. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 9.4. U.S. Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 9.4.1. Wholesalers
    • 9.4.2. Specialized Companies
    • 9.4.3. Public Authorities
    • 9.4.4. Others
  • 9.5. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 9.6. U.S. Pneumococcal Vaccines Market Forecast, by Sector
    • 9.6.1. Private
    • 9.6.2. Public
  • 10. Canada Pneumococcal Vaccines Market Analysis
  • 10.1. Canada Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 10.2. Canada Pneumococcal Vaccines Market Forecast, by Product Type
    • 10.2.1. Prevenar-13
    • 10.2.2. Synflorix
    • 10.2.3. V-114
    • 10.2.4. Pneumo - 23
    • 10.2.5. Pnuemovax-23
  • 10.3. Canada Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 10.4. Canada Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 10.4.1. Wholesalers
    • 10.4.2. Specialized Companies
    • 10.4.3. Public Authorities
    • 10.4.4. Others
  • 10.5. Canada Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 10.6. Canada Pneumococcal Vaccines Market Forecast, by Sector
    • 10.6.1. Private
    • 10.6.2. Public

11. Germany Pneumococcal Vaccines Market Analysis

  • 11.1. Germany Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 11.2. Germany Pneumococcal Vaccines Market Forecast, by Product Type
    • 11.2.1. Prevenar-13
    • 11.2.2. Synflorix
    • 11.2.3. V-114
    • 11.2.4. PCV-20
    • 11.2.5. Pnuemovax-23
  • 11.3. Germany Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 11.4. Germany Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 11.4.1. Wholesalers
    • 11.4.2. Specialized Companies
    • 11.4.3. Public Authorities
    • 11.4.4. Others
  • 11.5. Germany Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 11.6. Germany Pneumococcal Vaccines Market Forecast, by Sector
    • 11.6.1. Private
    • 11.6.2. Public

12. U.K. Pneumococcal Vaccines Market Analysis

  • 12.1. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 12.2. U.K. Pneumococcal Vaccines Market Forecast, by Product Type
    • 12.2.1. Prevenar-13
    • 12.2.2. Synflorix
    • 12.2.3. V-114
    • 12.2.4. PCV-20
    • 12.2.5. Pnuemovax-23
  • 12.3. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 12.4. U.K. Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 12.4.1. Wholesalers
    • 12.4.2. Specialized Companies
    • 12.4.3. Public Authorities
    • 12.4.4. Others
  • 12.5. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 12.6. U.K. Pneumococcal Vaccines Market Forecast, by Sector
    • 12.6.1. Private
    • 12.6.2. Public

13. France Pneumococcal Vaccines Market Analysis

  • 13.1. France Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 13.2. France Pneumococcal Vaccines Market Forecast, by Product Type
    • 13.2.1. Prevenar-13
    • 13.2.2. Synflorix
    • 13.2.3. V-114
    • 13.2.4. PCV-20
    • 13.2.5. Pnuemovax-23
  • 13.3. France Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 13.4. France Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 13.4.1. Wholesalers
    • 13.4.2. Specialized Companies
    • 13.4.3. Public Authorities
    • 13.4.4. Others
  • 13.5. France Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 13.6. France Pneumococcal Vaccines Market Forecast, by Sector
    • 13.6.1. Private
    • 13.6.2. Public

14. Italy Pneumococcal Vaccines Market Analysis

  • 14.1. Italy Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 14.2. Italy Pneumococcal Vaccines Market Forecast, by Product Type
    • 14.2.1. Prevenar-13
    • 14.2.2. Synflorix
    • 14.2.3. V-114
    • 14.2.4. PCV-20
    • 14.2.5. Pnuemovax-23
  • 14.3. Italy Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 14.4. Italy Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 14.4.1. Wholesalers
    • 14.4.2. Specialized Companies
    • 14.4.3. Public Authorities
    • 14.4.4. Others
  • 14.5. Italy Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 14.6. Italy Pneumococcal Vaccines Market Forecast, by Sector
    • 14.6.1. Private
    • 14.6.2. Public

15. Spain Pneumococcal Vaccines Market Analysis

  • 15.1. Spain Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 15.2. Spain Pneumococcal Vaccines Market Forecast, by Product Type
    • 15.2.1. Prevenar-13
    • 15.2.2. Synflorix
    • 15.2.3. V-114
    • 15.2.4. PCV-20
    • 15.2.5. Pnuemovax-23
  • 15.3. Spain Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 15.4. Spain Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 15.4.1. Wholesalers
    • 15.4.2. Specialized Companies
    • 15.4.3. Public Authorities
    • 15.4.4. Others
  • 15.5. Spain Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 15.6. Spain Pneumococcal Vaccines Market Forecast, by Sector
    • 15.6.1. Private
    • 15.6.2. Public

16. Belgium Pneumococcal Vaccines Market Analysis

  • 16.1. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 16.2. Belgium Pneumococcal Vaccines Market Forecast, by Product Type
    • 16.2.1. Prevenar-13
    • 16.2.2. Synflorix
    • 16.2.3. V-114
    • 16.2.4. PCV-20
    • 16.2.5. Pnuemovax-23
  • 16.3. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 16.4. Belgium Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 16.4.1. Wholesalers
    • 16.4.2. Specialized Companies
    • 16.4.3. Public Authorities
    • 16.4.4. Others
  • 16.5. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 16.6. Belgium Pneumococcal Vaccines Market Forecast, by Sector
    • 16.6.1. Private
    • 16.6.2. Public

17. India Pneumococcal Vaccines Market Analysis

  • 17.1. India Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 17.2. India Pneumococcal Vaccines Market Forecast, by Product Type
    • 17.2.1. Prevenar-13
    • 17.2.2. Synflorix
    • 17.2.3. SIIL PCV-10
    • 17.2.4. PCV-20
    • 17.2.5. Pnuemovax-23
  • 17.3. India Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 17.4. India Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 17.4.1. Wholesalers
    • 17.4.2. Specialized Companies
    • 17.4.3. Public Authorities
    • 17.4.4. Others
  • 17.5. India Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 17.6. India Pneumococcal Vaccines Market Forecast, by Sector
    • 17.6.1. Private
    • 17.6.2. Public

18. China Pneumococcal Vaccines Market Analysis

  • 18.1. China Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 18.2. China Pneumococcal Vaccines Market Forecast, by Product Type
    • 18.2.1. Prevenar-13
    • 18.2.2. PCV 13 (pipeline)
    • 18.2.3. PPSV 23
  • 18.3. China Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 18.4. China Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 18.4.1. Wholesalers
    • 18.4.2. Specialized Companies
    • 18.4.3. Public Authorities
    • 18.4.4. Others
  • 18.5. China Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 18.6. China Pneumococcal Vaccines Market Forecast, by Sector
    • 18.6.1. Private
    • 18.6.2. Public

19. Japan Pneumococcal Vaccines Market Analysis

  • 19.1. Japan Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 19.2. Japan Pneumococcal Vaccines Market Forecast, by Product Type
    • 19.2.1. Prevenar-13
    • 19.2.2. Synflorix
    • 19.2.3. PPSV 23
  • 19.3. Japan Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 19.4. Japan Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 19.4.1. Wholesalers
    • 19.4.2. Specialized Companies
    • 19.4.3. Public Authorities
    • 19.4.4. Others
  • 19.5. Japan Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 19.6. Japan Pneumococcal Vaccines Market Forecast, by Sector
    • 19.6.1. Private
    • 19.6.2. Public

20. Australia Pneumococcal Vaccines Market Analysis

  • 20.1. Australia Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 20.2. Australia Pneumococcal Vaccines Market Forecast, by Product Type
    • 20.2.1. Prevenar-13
    • 20.2.2. Synflorix
    • 20.2.3. V114
    • 20.2.4. Pnuemovax-23
  • 20.3. Australia Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 20.4. Australia Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 20.4.1. Wholesalers
    • 20.4.2. Specialized Companies
    • 20.4.3. Public Authorities
    • 20.4.4. Others
  • 20.5. Australia Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 20.6. Australia Pneumococcal Vaccines Market Forecast, by Sector
    • 20.6.1. Private
    • 20.6.2. Public

21. New Zealand Pneumococcal Vaccines Market Analysis

  • 21.1. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 21.2. New Zealand Pneumococcal Vaccines Market Forecast, by Product Type
    • 21.2.1. Prevenar-13
    • 21.2.2. Synflorix
    • 21.2.3. Pnuemovax-23
  • 21.3. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 21.4. New Zealand Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 21.4.1. Wholesalers
    • 21.4.2. Specialized Companies
    • 21.4.3. Public Authorities
    • 21.4.4. Others
  • 21.5. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 21.6. New Zealand Pneumococcal Vaccines Market Forecast, by Sector
    • 21.6.1. Private
    • 21.6.2. Public

22. Brazil Pneumococcal Vaccines Market Analysis

  • 22.1. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 22.2. Brazil Pneumococcal Vaccines Market Forecast, by Product Type
    • 22.2.1. Prevenar-13
    • 22.2.2. Synflorix
    • 22.2.3. Pnuemovax-23
  • 22.3. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 22.4. Brazil Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 22.4.1. Wholesalers
    • 22.4.2. Specialized Companies
    • 22.4.3. Public Authorities
    • 22.4.4. Others
  • 22.5. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 22.6. Brazil Pneumococcal Vaccines Market Forecast, by Sector
    • 22.6.1. Private
    • 22.6.2. Public

23. Mexico Pneumococcal Vaccines Market Analysis

  • 23.1. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 23.2. Mexico Pneumococcal Vaccines Market Forecast, by Product Type
    • 23.2.1. Prevenar-13
    • 23.2.2. Synflorix
    • 23.2.3. Pnuemovax-23
  • 23.3. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 23.4. Mexico Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 23.4.1. Wholesalers
    • 23.4.2. Specialized Companies
    • 23.4.3. Public Authorities
    • 23.4.4. Others
  • 23.5. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 23.6. Mexico Pneumococcal Vaccines Market Forecast, by Sector
    • 23.6.1. Private
    • 23.6.2. Public

24. Rest of the World Pneumococcal Vaccines Market Analysis

  • 24.1. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 24.2. Rest of the World Pneumococcal Vaccines Market Forecast, by Product Type
    • 24.2.1. Prevenar-13
    • 24.2.2. Synflorix
    • 24.2.3. V-114
    • 24.2.4. PCV-20
    • 24.2.5. PCV-10 (SII)
    • 24.2.6. Pnuemovax-23
  • 24.3. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 24.4. Rest of the World Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 24.4.1. Wholesalers
    • 24.4.2. Specialized Companies
    • 24.4.3. Public Authorities
    • 24.4.4. Others
  • 24.5. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 24.6. Rest of the World Pneumococcal Vaccines Market Forecast, by Sector
    • 24.6.1. Private
    • 24.6.2. Public
  • 24.7. Rest of the World Pneumococcal Vaccines Market Forecast, by Region

25. Competition Landscape

  • 25.1. Global Pneumococcal Vaccines Market Share Analysis, by Company (2017)
  • 25.2. Company Profiles
    • 25.2.1. Pfizer, Inc.
    • 25.2.2. Merck & Co., Inc.
    • 25.2.3. SK Chemicals
    • 25.2.4. Serum Institute of India Pvt. Ltd.
    • 25.2.5. Chengdu Institute of Biological Products Co., Ltd.
    • 25.2.6. GlaxoSmithKline plc
    • 25.2.7. Sanofi
    • 25.2.8. Walvax Biotechnology Co., Ltd.

List of Tables

  • TABLE 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 2 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 3 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 4 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 5 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 6 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 7 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 8 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 9 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 10 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 11 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 12 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 13 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 14 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 15 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 16 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 17 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 18 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 19 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 20 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 21 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 22 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 23 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 24 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 25 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 26 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 27 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 28 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 29 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 30 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 31 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 32 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 33 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 34 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 35 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 36 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 37 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 38 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 39 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 40 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 41 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 42 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 43 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 44 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 45 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 46 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 47 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 48 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 49 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 50 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 51 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 52 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 53 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 54 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 55 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 56 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 57 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 58 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 59 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 60 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 61 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 62 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 63 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 64 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 65 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 68 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • TABLE 69 North America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • TABLE 70 Europe Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • TABLE 71 Asia Pacific Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • TABLE 72 Latin America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026

List of Figures

  • FIG. 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, 2016-2026
  • FIG. 2 Global Pneumococcal Vaccines Market Value Share (%), by Product Type (2017)
  • FIG. 3 Global Pneumococcal Vaccines Market Value Share (%), by Sector (2017)
  • FIG. 4 Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel (2017)
  • FIG. 5 Global Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 6 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent, 2016-2026
  • FIG. 7 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent (pipeline), 2016-2026
  • FIG. 8 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent, 2016-2026
  • FIG. 9 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent (pipeline), 2016-2026
  • FIG. 10 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 15-Valent (pipeline), 2016-2026
  • FIG. 11 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 20-Valent (pipeline), 2016-2026
  • FIG. 12 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 23-Valent, 2016-2026
  • FIG. 13 Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 14 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Wholesalers, 2016-2026
  • FIG. 15 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialized Companies, 2016-2026
  • FIG. 16 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public Authorities, 2016-2026
  • FIG. 17 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
  • FIG. 18 Global Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 19 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public, 2016-2026
  • FIG. 20 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Private, 2016-2026
  • FIG. 21 U.S. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 22 U.S. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 23 U.S. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 24 Canada Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 25 Canada Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 26 Canada Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 27 Germany Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 28 Germany Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 29 Germany Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 30 U.K. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 31 U.K. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 32 U.K. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 33 France Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 34 France Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 35 France Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 36 Italy Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 37 Italy Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 38 Italy Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 39 Spain Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 40 Spain Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 41 Spain Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 42 Belgium Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 43 Belgium Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 44 Belgium Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 45 India Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 46 India Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 47 India Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 48 China Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 49 China Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 50 China Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 51 Japan Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 52 Japan Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 53 Japan Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 54 New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 55 Australia Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 56 Australia Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 57 New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 58 New Zealand Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 59 New Zealand Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 60 Brazil Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 61 Brazil Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 62 Brazil Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 63 Mexico Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 64 Mexico Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 65 Mexico Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 68 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 69 Global Pneumococcal Vaccines Market Share (%) and Market Share Range (%), by Company, 2017